期刊文献+

血管内皮生长因子和转化生长因子-β2对人视网膜色素上皮细胞分化及其介导胶原凝胶收缩的机制研究 被引量:1

Critical role and involvement of vascular endothelial growth factor and transforming growth factor-β2 in collagen gel contraction induced by retinal pigment epithelial cells
原文传递
导出
摘要 目的研究血管内皮生长因子(VEGF)与转化生长因子(TGF)-β2对人视网膜色素上皮(RPE)细胞分化及其介导胶原凝胶收缩的机制。方法实验研究。原代培养人RPE细胞,将其与I型胶原凝胶混合,观察细胞在胶原中的收缩情况。实验分为3组,VEGF(50μg/L)组、TGF—β2(5μg/L)组和对照组,比较3组凝胶收缩性状的变化。同时,对人RPE细胞的增殖、形态和分化演变趋势进行分析。3组检测数据的多重比较采用单因素方差分析,进一步两两比较采用SNK—q检验。结果与I型胶原凝胶混合后,VEGF组和TGF—β2组的凝胶收缩率均表现出时间相关性,于24、48、72h分别达到(34.7±3.1)%、(44.3±6.0)%、(44.0±7.2)%和(29.3±3.1)%、(31.7±3.5)%、(29.0±3.6)%。与对照组[(20.0±0.5)%、(17.3±3.6)%、(19.1±0.8)%]相比,各时间点凝胶收缩率差异均有统计学意义(24h:F=26.220,P=0.001;48h:F=26.796,P=0.001;72h:F=21.522,P=0.002);3组间各时间点两两比较差异亦有统计学意义(SNK—q检验,P〈0.05)。免疫印迹法检测两个实验组内各时点人RPE细胞内α-平滑肌肌动蛋白(α-SMA)表达水平,差异均有统计学意义(TGF-p2组:F=1.134,P:0.000;各时间点:SNK—q检验,P〈0.05;VEGF组:F=279.179,P=0.000;各时间点:SNK—q检验,P〈0.05)。进一步两两比较,TGF-β2组胶原凝胶收缩效应较VEGF组显著(6h:F=3.646,P=0.000;24h:F=18.706,P=0.003;48h:F=124.195,P=0.000;72h:F=76.811,P=0.000)。倒置显微镜与激光扫描共焦显微镜下观察可见,TGF-β2组和VEGF组人RPE细胞形态均发生了成纤维细胞样转化。结论VEGF和TGF-β2均可诱导人RPE细胞发生成纤维细胞样转化,从而引起胶原凝胶的收缩性状改变,这可能是玻璃体视网膜界面性疾病发生、发展的机制之一. Objective To investigate the influence of vascular endothelial growth factor (VEGF) and transforming growth factor (TGF)-β2 to human retinal pigment epithelium(RPE) cell differentiation,and the mechanism of collagen gel contraction mediated by RPE cells. Methods Experiment study. An in vitro collagen gel contraction assay was performed to evaluate the effect of cultured human RPE in addition of VEGF and TGF-β2 at indicated time points (24 h,48 h and 72 h). Three groups were established in the experiment :control group,50 μg/L VEGF group and 5 μg/L TGF-132 group. The effects of both cytokines on the collagen gel contraction were analyzed by the reduced diameter of the collagen gel. And the changes of cell morphology and their transdifferentiation were assessed to estimate the possible connection between RPE transdifferentiation and collagen gel contraction. One-way ANOVA was used in conjunction with SNK-q test to assess statistical significance at different time periods within groups. Results There were differences on collagen gel contraction rates among VEGF group [ ( 34.7 ± 5.1 ) %, ( 44. 3 ± 6.0 ) %, ( 44.0 ± 7.2 ) % ], TGF-β2 group [ (29. 3 ± 3. 1 ) %, ( 31.7 ± 3.5 ) %, ( 29. 0 ±3.6 ) % ] and control group [ ( 20. 0 ± 0. 5 ) %, ( 17.3 ± 3.6) %, ( 19. 1 ± 0. 8 ) % ] at 24 h,48 h and 72 h after cultured ( 24 h : F = 26. 220, P = 0. 001 ; 48 h :F = 26. 796 ,P = 0. 001 ;72 h:F = 21. 522, P = 0. 002), and on each time point two two comparison in the three groups ( SNK-q test, P 〈 0.05 ). There were differences on protein expression level of α-smooth muscle actin(α-SMA) in 50 μg/L VEGF group and 5 μg/L TGF-β2 group at difference time points, respectively ( TGF-β2 group : F = 1.134, P = 0, 000 ; each time point : SNK-q test, P 〈 0.05 ; VEGF group : F = 279. 179 ,P = 0. 000 ; each time point : SNK-q test, P 〈 0.05 ). Moreover, TGF-132 ( 5 p.g/L) demonstrated stronger and more permanent gel contraction than VEGF(50 μg/L)(6 h:F- 3. 646,P =0. 000;24 h:F = 18. 706,P =0. 003;48 h:F= 124. 195,P =0. 000;72 h:F =76. 811 ,P =0. 000). RPE cells' form happened fibroblasts sample transformation in both VEGF group and TGF-132 group . Conclusions Both VEGF and TGF-β2 can induce the collagen gel contraction, partly by means of inducing the expression of α-SMA and RPE contraction, which may thus contribute to the explanations of vitro-retinal diseases.
出处 《中华眼科杂志》 CAS CSCD 北大核心 2012年第1期52-60,共9页 Chinese Journal of Ophthalmology
基金 国家自然科学基金(30872824/C170602) 浙江省自然科学基金(J20050897)
关键词 色素上皮 血管内皮生长因子A 转化生长因子Β2 胶原 Pigment epithelium of eye Vascular endothelial growth factor A Transforming growth factor beta 2 Collagen
  • 相关文献

参考文献33

  • 1Koerner F, Garweg J. Diseases of vitreo-macular interface. Klin Monbl Augenheilkd, 1999,214 : 305-310.
  • 2Sebag J, Hageman GS. Interfaces. Eur J Ophthalmol,2000,10:1- 3.
  • 3Sebag J. Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease. Graefes Arch Clin Exp Ophthalmol, 2004,242 : 690-698.
  • 4Gandorfer A, Rohleder M, Kampik A. Epiretinal pathology of vitreomacular traction syndrome. Br J Ophthalmol, 2002,86 : 902- 909.
  • 5Carrington L,McLeod D,Boulton M. IL-10 and antibodies to TGF- beta2 and PDGF inhibit RPE-mediated retinal contraction. Invest Ophthalmol Vis Sci ,2000,41 : 1210-1216.
  • 6Yokoi T, Koide R, Matsuoka K, et al. Analysis of the vitreous membrane in a case of type 1 Stickler syndrome. Graefes Arch Clin Exp Ophthalmol, 2009,247 : 715 -718.
  • 7Hollborn M,Iandiev I, Seifert M, et al. Expression of HB-EGF by retinal pigment epithelial cells in vitreoretinal proliferative disease. Curr Eye Res, 2006,31 : 863-874.
  • 8Saika S. TGFbeta pathobiology in the eye. Lab Invest, 2006,86: 106-115.
  • 9Matsuyama K,Ogata N, Jo N, et al. Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab. Jpn J Ophthalmol, 2009,53:243-248.
  • 10Rotsos T, Sagoo MS, daCruz L, et al. Intravitreal anti-VEGF treatment in eyes with combined choroidal neovascularisation and vitreomacular traction syndrome. Br J Ophthalmol, 2010,94 : 1205- 1210.

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部